A Phase II Study of Preradiotherapy Chemotherapy Followed by Hyperfractionated Radiotherapy for Newly Diagnosed High-Risk Medulloblastoma/Primitive Neuroectodermal Tumor: A Report From the Children's Oncology Group (CCG 9931)

This publication has 25 references indexed in Scilit:

• Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
  Journal of Clinical Oncology, 2006
• Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Importance of radiation time and dose factors on outcome for childhood medulloblastoma*
  Australasian Radiology, 2005
• Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy
  European Journal Of Cancer, 2005
• Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study
  Acta Oncologica, 2005
• Reducing Toxicity from Craniospinal Irradiation
  The Cancer Journal, 2004
• Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89.
  Klinische Padiatrie, 1998
• Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Preradiation chemotherapy in advanced medulloblastoma a pediatric oncology group pilot study
  Cancer, 1993
• High-dose Carboplatin in Combination with Etoposide (JET Regimen) for Childhood Brain Tumors
  Journal of Pediatric Hematology/Oncology, 1990